Sun Pharma Advanced Research’s stock rallied sharply towards the end of 2023. But since the beginning of this year, it was largely trading in a broad sideways trend. Last week, it gained nearly 18 per cent, indicating that the stock has resumed the uptrend. While there is a chance for the price to see a corrective decline to ₹400 from here, we expect it to eventually rally to ₹500 in the short term. Therefore, participants can consider buying this stock now at ₹433 and accumulate if the price dips to ₹405. Place stop-loss at ₹375. When the stock touches ₹460, tighten the stop-loss to ₹435. Raise the stop-loss further to ₹460 when the stock hits ₹485. Book profits at ₹500.
(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)
![comment](https://assetsbl.thehindubusinessline.com/theme/images/bl-online/1x1_spacer.png)
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.